Skip to content

3D Printed Personalized Extendable Prosthesis

3D Printed Personalized Extendable Prosthesis Replacement for Limb Preservation in Children With Osteosarcoma: a Preliminary Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05794594
Enrollment
25
Registered
2023-04-03
Start date
2015-10-01
Completion date
2023-03-01
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteosarcoma in Children

Brief summary

The goal of this type of observational study is to investigate the preliminary effect of 3D printed personalized extendable prosthesis replacement on limb salvage in children with osteosarcoma. The main question it aims to answer is: Is 3D printed personalized extendable prosthesis replacement has a good outcome in limb salvage pediatric osteosarcoma?

Detailed description

Osteosarcoma is one of the most common primary malignant bone tumors in children and adolescents. In this study, the investigators try to investigate the preliminary effect of 3D printed personalized extendable prosthesis replacement on limb salvage in children with osteosarcoma.

Interventions

DEVICE3D printed personalized extendable prosthesis

3D printed personalized extendable prosthesis replacement for limb preservation in children

Sponsors

Yuxi Su
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* tumors of the extremities, with moderate soft-tissue invasion * the neurovascular bundle is not invaded, and the tumor can be excised totally * no metastatic lesions or metastases can be cured

Exclusion criteria

* recurrent tumors * poorly differentiated tumors * poor soft-tissue conditions * neurovascular invasion around tumors * ineffective chemotherapy with metastasis

Design outcomes

Primary

MeasureTime frameDescription
Recurrence7yearsOsteosarcoma recurrence rate

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026